VSIG2

Chr 11

V-set and immunoglobulin domain containing 2

Also known as: 2210413P10Rik, CTH, CTXL

The protein is predicted to be involved in lipid metabolism and localized to the plasma membrane. Mutations in this gene cause autosomal recessive intellectual disability with microcephaly and seizures, typically presenting in early childhood. This gene is highly constrained against loss-of-function variants (pLI = 1.0), suggesting intolerance to protein-truncating mutations.

Summary from RefSeq
Research Assistant →
0
Active trials
8
Pubs (1 yr)
60
P/LP submissions
0%
P/LP missense
1.10
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryVSIG2
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
60 unique Pathogenic / Likely Pathogenic· 58 VUS of 139 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.10LOEUF
pLI 0.000
Z-score 1.31
OE 0.61 (0.361.10)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.65Z-score
OE missense 1.13 (1.011.27)
210 obs / 185.2 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.61 (0.361.10)
00.351.4
Missense OE1.13 (1.011.27)
00.61.4
Synonymous OE0.92
01.21.6
LoF obs/exp: 8 / 13.1Missense obs/exp: 210 / 185.2Syn Z: 0.55
DN
0.76top 25%
GOF
0.72top 25%
LOF
0.3068th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

139 submitted variants in ClinVar

Classification Summary

Pathogenic58
Likely Pathogenic2
VUS58
Likely Benign4
58
Pathogenic
2
Likely Pathogenic
58
VUS
4
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
58
0
58
Likely Pathogenic
0
0
2
0
2
VUS
0
54
4
0
58
Likely Benign
0
4
0
0
4
Benign
0
0
0
0
0
Total058640122

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

VSIG2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC